[Adults] {Spam? 3.69} Nuvilex, Inc., John_son & John_son, and Med tronic, Inc. , All Developing Type of Artificial Pancreas for Diabetics

[Newsletter]

Nuvilex Inc.'s (NVLX)

Nuvilex, Inc., Johnson & Johnson, and Med_tronic, Inc. , All Inventing Type
of Artificial Pancreas for Diabetics



While Med_tronic, Inc. (NYSE: M_D_T) and Johnson & John_son (NYSE: J-N-J)
are creating devices that can essentially perform as a type of "artificial
pancreas," Nuvilex, Inc. (NVLX) unique cell encapsulation technology has
revealed it too can invent a type of "artificial pancreas" in preclinical
diabetes studies. Their tactics couldn't be more unalike; however, all
three companies are confident that inventing an artificial pancreas offers
diabetics the best answer to independently monitor their blo_od sugar
levels, and in exchange, supply them with insulin when desired.

As the two N-Y-S-E-traded entities turn to medical devices embody their
brand of artificial pancreas, the small, Silver Spring, Maryland-based
biotech, Nuvilex, is turning to a much more minor and different choice –
transplanted living, insulin-producing cells inserted in capsules just
about the size of the head of a pin, that create a bundle and act as a
miniature cell factory that creates insulin upon demand inside the
diabetics physique.

701 Fifth Ave, 42nd Floor, Seattle, Wash. 98104-5119 USA

The use of research materials circulated by the auth.or is done at your own
risk. You are encouraged to do your own research before making any
investment decision in regards to the secu rity discussed herein. The
author has not been rewarded by any entity in connection with the
distribution of these materials. You should presume that as of the date of
this report or letter, the author, possibly along with or through our
owners, affiliates, employees and/or consultants, (cooperatively referred
to as the author) has a position in all company shares (and/or options of
the shares) covered herein that is consistent with the position set forth
in our report. In connection with NVLX, the author has taken a long
position. Following the disbursement of any report or letter, the author
intends to continue engaging in trnsactns in the secu rity covered herein,
and we may be long, short, and/or neutral at any time hereafter regardless
of our initial position and we preserve the right to procure or trade all
or part of our position at any time without notice. This practice could end
in our trading securities at any time before, during, and/or after the
disbursement of this report.

Remove me from this mailing
http://support.bifurcadaregardedbi.net/unsubscribe.php?M=6588707&C=0a89a74737fe0ab850bde605efc11be4&L=54&N=1867

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.polarhome.com/pipermail/adults/attachments/20130801/c3513512/attachment.html>